Literature DB >> 21738132

As E. coli continues to claim lives, new approaches offer hope.

Elie Dolgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21738132     DOI： 10.1038/nm0711-755

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2.

Authors:  Claudia Silberstein; María S Lucero; Elsa Zotta; Diane P Copeland; Li Lingyun; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  A novel antimicrobial peptide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes.

Authors:  M Lino; J V Kus; S L Tran; Z Naqvi; B Binnington; S D Goodman; A M Segall; D Barnett Foster
Journal:  Microbiology (Reading)       Date:  2011-03-31       Impact factor: 2.777

3.  Virulence inhibition by zinc in shiga-toxigenic Escherichia coli.

Authors:  John K Crane; Isaac Wyatt Byrd; Edgar C Boedeker
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441
  3 in total
  6 in total

1.  Novel antimicrobial peptide prevents C. rodentium infection in C57BL/6 mice by enhancing acid-induced pathogen killing.

Authors:  Tracy Lackraj; Kathene Johnson-Henry; Philip M Sherman; Steve D Goodman; Anca M Segall; Debora Barnett Foster
Journal:  Microbiology       Date:  2016-07-13       Impact factor: 2.777

Review 2.  Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Authors:  Maite Muniesa; Jens A Hammerl; Stefan Hertwig; Bernd Appel; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

3.  Potentiation of Antibiotics by a Novel Antimicrobial Peptide against Shiga Toxin Producing E. coli O157:H7.

Authors:  Juan Puño-Sarmiento; Erin M Anderson; Amber J Park; Cezar M Khursigara; Debora E Barnett Foster
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

Review 4.  Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract.

Authors:  Debora Barnett Foster
Journal:  Virulence       Date:  2013-04-03       Impact factor: 5.882

5.  Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Authors:  Yahsou Delmas; Benoît Vendrely; Benjamin Clouzeau; Hiba Bachir; Hoang-Nam Bui; Adeline Lacraz; Sébastien Hélou; Cécile Bordes; Armel Reffet; Brigitte Llanas; Sophie Skopinski; Patrick Rolland; Didier Gruson; Christian Combe
Journal:  Nephrol Dial Transplant       Date:  2013-11-28       Impact factor: 5.992

6.  Hemolytic uremic syndrome: late renal injury and changing incidence-a single centre experience in Canada.

Authors:  Pierre Robitaille; Marie-José Clermont; Aïcha Mérouani; Véronique Phan; Anne-Laure Lapeyraque
Journal:  Scientifica (Cairo)       Date:  2012-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.